Tocilizumab In Patients With Rheumatoid Arthritis and Rates Of Malignancy: Results From Long-Term Extension Clinical Trials

被引：0
|
作者：
van Vollenhoven, Ronald F. [1 ]
Rubbert-Roth, Andrea [2 ]
Sebba, Anthony [3 ]
Porter-Brown, Benjamin [4 ]
Rowell, Lucy [4 ]
Napalkov, Pavel [5 ]
Smart, Devi [4 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Univ Cologne, D-50931 Cologne, Germany
[3] Univ S Florida, Tampa, FL USA
[4] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[5] Genentech Inc, San Francisco, CA 94080 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2351
引用
收藏
页码：S1005 / S1005
页数：1
相关论文
共 50 条
  • [21] New insights and long-term safety of tocilizumab in rheumatoid arthritis
    Jones, Graeme
    Panova, Elena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (10) : 195 - 199
  • [22] SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS UP TO 3.5 YEARS OF TREATMENT IN LONG-TERM EXTENSION STUDIES
    Tate, G.
    Scali, J.
    Monge, P.
    Kissel, K.
    Alecock, E.
    van Vollenhoven, R. F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S43 - S44
  • [23] Long-term Results of Shoulder Hemiarthroplasty in Patients With Rheumatoid Arthritis
    Geervliet, Pieter C.
    Somford, Matthijs P.
    Winia, Paul
    van den Bekerom, Michel P. J.
    ORTHOPEDICS, 2015, 38 (01) : E38 - E42
  • [24] Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
    Cacciapaglia, Fabio
    Anelli, Maria Grazia
    Rinaldi, Angela
    Fornaro, Marco
    Lopalco, Giuseppe
    Scioscia, Crescenzio
    Lapadula, Giovanni
    Iannone, Florenzo
    MEDIATORS OF INFLAMMATION, 2018, 2018
  • [25] Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
    Buch, Maya H.
    Aletaha, Daniel
    Combe, Bernard G.
    Tanaka, Yoshiya
    Caporali, Roberto
    Schulze-Koops, Hendrik
    Takeuchi, Tsutomu
    Gottenberg, Jacques-Eric
    Blanco, Ricardo
    Verschueren, Patrick
    Zubrzycka-Sienkiewicz, Anna
    De Leonardis, Francesco
    Omoruyi, Edmund V. Ekoka
    Rajendran, Vijay
    Emery, Paul
    RMD OPEN, 2024, 10 (04):
  • [26] The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab
    Sagawa, Akira
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 352 - 358
  • [27] LONG-TERM SAFETY OF RITUXIMAB: FOLLOW UP OF THE RHEUMATOID ARTHRITIS CLINICAL TRIALS
    van Vollenhoven, Ronald
    Emery, Paul
    Bingham, Clifton, III
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Macey, Katherine M.
    Sweetser, Marianne T.
    Lehane, Patricia
    Farmer, Pamela
    Long, Simon G.
    RHEUMATOLOGY, 2011, 50 : 127 - 128
  • [28] Long-term safety of adalimumab (humira®) in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, A
    Kupper, H
    Spencer-Green, GT
    RHEUMATOLOGY, 2005, 44 : I70 - I71
  • [29] GASTROINTESTINAL SAFETY OF TOCILIZUMAB: DATA FROM PATIENTS WITH RHEUMATOID ARTHRITIS IN ROCHE CLINICAL TRIALS AND CLINICAL PRACTICE
    Van Vollenhoven, Ronald
    Keystone, Edward
    Furie, Richard
    Blesch, Anne
    Wang, Candace D.
    Curtis, Jeffrey R.
    RHEUMATOLOGY, 2010, 49 : I103 - I103
  • [30] Long-term results of silicone wrist arthroplasty in patients with rheumatoid arthritis
    Kistler, U
    Weiss, APC
    Simmen, BR
    Herren, DB
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2005, 30A (06): : 1282 - 1287
12345